A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes.

Journal of Process Control
Cesar C PalermF J Doyle

Abstract

Maintaining good glycemic control is a daily challenge for people with type 1 diabetes. Insulin requirements are changing constantly due to many factors, such as levels of stress and physical activity. The basal insulin requirement also has a circadian rhythm, adding another level of complexity. Automating the adjustment of insulin dosing would result in improved glycemic control, as well as an improved quality of life by significantly reducing the burden on the patient. Building on our previous success of using run-to-run control for prandial insulin dosing (a strategy adapted from the chemical process industry), we show how this same framework can be used to adjust basal infusion profiles. We present a mathematical model of insulin-glucose dynamics which we augment in order to capture the circadian variation in insulin requirements. Using this model, we show that the run-to-run framework can also be successfully applied to adjust basal insulin dosing.

References

Jul 1, 1990·Computer Methods and Programs in Biomedicine·J BeyerG Schulz
Nov 1, 1985·Diabetes Care·A SchiffrinA M Albisser
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Feb 5, 1999·IEEE Transactions on Bio-medical Engineering·R S ParkerN A Peppas
Jul 9, 2002·Computer Methods and Programs in Biomedicine·Jürgen SchrezenmeirPeter Papazov
Mar 29, 2003·Diabetes Care·Jill Weissberg-BenchellRoopa Seshadri
Nov 5, 2003·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Yasuto MatsuoEiichi Araki
Jan 27, 2004·Advanced Drug Delivery Reviews·G M SteilK Rebrin
Jul 2, 2004·ILAR Journal·Larissa EiseleinJohn C Rutledge
Aug 17, 2004·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Taiji SekigamiEiichi Araki
Sep 24, 2004·Physiological Measurement·Roman HovorkaMalgorzata E Wilinska
Jan 18, 2005·IEEE Transactions on Bio-medical Engineering·Malgorzata E WilinskaRoman Hovorka
Mar 2, 2005·Diabetes Technology & Therapeutics·Howard ZisserCamelia Owens
Dec 24, 2005·The New England Journal of Medicine·William T Cefalu
Jan 18, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·R Hovorka
Jun 10, 2006·IEEE Transactions on Bio-medical Engineering·Camelia OwensFrancis J Doyle
Feb 23, 2007·Diabetes/metabolism Research and Reviews·Wendy C BevierLois Jovanovic
Oct 20, 2007·Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society·Gianni MarchettiDale E Seborg
Nov 24, 2007·Diabetes Technology & Therapeutics·Howard C ZisserLois Jovanovic

❮ Previous
Next ❯

Citations

Jul 27, 2010·Medical & Biological Engineering & Computing·Amjad Abu-RmilehDarine Zambrano
Aug 3, 2012·Diabetes Technology & Therapeutics·Howard C Zisser
Jun 24, 2014·IEEE Journal of Biomedical and Health Informatics·Pau HerreroChristofer Toumazou
Jan 1, 2009·IEEE Reviews in Biomedical Engineering·Claudio CobelliBoris P Kovatchev
Apr 17, 2012·Computer Methods and Programs in Biomedicine·Elena DaskalakiStavroula G Mougiakakou
Feb 22, 2012·Computer Methods and Programs in Biomedicine·Colleen Hughes-KarvetskiBoris P Kovatchev
Jun 13, 2012·Diabetes·Marc BretonUNKNOWN International Artificial Pancreas Study Group
Jun 27, 2013·Diabetes·Dirk Jan StenversSusanne E la Fleur
Oct 26, 2011·Diabetes·Claudio CobelliBoris Kovatchev
Jan 4, 2013·Computer Methods in Biomechanics and Biomedical Engineering·M L Fravolini, P G Fabietti
May 20, 2015·Computer Methods and Programs in Biomedicine·Jianyong TuoYouqing Wang
Feb 11, 2010·Journal of Diabetes Science and Technology·Lalo MagniClaudio Cobelli
Feb 11, 2010·Journal of Diabetes Science and Technology·Youqing WangFrancis J Doyle
Feb 11, 2010·Journal of Diabetes Science and Technology·Howard ZisserLois Jovanovic
Jul 26, 2017·Journal of Diabetes Science and Technology·John WalshLutz Heinemann
Jan 17, 2017·IEEE Transactions on Bio-medical Engineering·Chiara ToffaninClaudio Cobelli
Mar 2, 2018·Journal of Diabetes Science and Technology·Pau HerreroPantelis Georgiou
Oct 17, 2017·Journal of Diabetes Science and Technology·Stamatina ZavitsanouEyal Dassau
Feb 7, 2019·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Ericles Andrei BelleiAna Carolina Bertoletti De Marchi
Feb 23, 2019·Diabetes Care·David J Pettitt, Alison Okada Wollitzer
Nov 23, 2019·Science·Philip S ThomasEmma Brunskill
Jan 27, 2019·Bioengineering & Translational Medicine·Dawei ShiFrancis J Doyle
Sep 29, 2019·Journal of Diabetes Science and Technology·Iman HajizadehAli Cinar
Aug 16, 2017·Current Diabetes Reports·Ali Cinar
Apr 24, 2018·Journal of Diabetes Science and Technology·Florian ReitererKirsten Nørgaard
Apr 10, 2013·Journal of Diabetes Science and Technology·Benyamin GrosmanBarry Keenan
Jul 23, 2020·Nature Metabolism·Nichole S TylerPeter G Jacobs
Jun 11, 2020·Sensors·Nichole S Tyler, Peter G Jacobs
Nov 19, 2020·International Journal of Endocrinology·Guillermo Edinson Guzman GómezOscar Fernando Bedoya Leiva
Mar 16, 2021·Journal of Diabetes Science and Technology·Azure D GrantLance J Kriegsfeld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.